Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2014 / Nov / Demystifying 2D-LC
Pharma and Biopharma Food, Beverage & Agriculture Omics Metabolomics & Lipidomics Sponsored

Demystifying 2D-LC

In early 2014, Agilent Technologies approached us with a clear objective: to show how simple and robust two-dimensional liquid chromatography has become. Here, we present the results from our fruitful collaboration.

11/28/2014 1 min read

Sponsored By

Share

1114-802-clouds

Over the course of the last six months, we’ve had the great pleasure of working with some of biggest names in the field, covering key application areas, such as biopharmaceuticals and traditional chinese medicine analysis, as we went. In this special compendium, the RIC’s Pat Sandra and Gerd Vanhoenacker begin with “Embracing the Second Dimension”, which provides essential background theory and introduces 2D-LC as the answer to the demand for higher peak capacity in complex samples. “The New 2D-LC Kids on the Block”, meanwhile, features two scientists who have more recently embraced the second dimension, openly asking them about their experiences. Other authors include Genentech’s Cadapakam J. Venkatramani and Oliver Schmitz from the University Duisberg-Essen.

To really send the message home, a further two authors – Koen Sandra and Dwight Stoll – recently delivered a webinar to delve even deeper into certain aspects of practical 2D-LC and answered your questions. You can access the on-demand version here

Both Agilent and The Analytical Scientist consider this compendium to be the beginning of the discussion on 2D-LC – not the end. We look forward to receiving your questions and feedback – please feel free to use the comment section below.

Download the Demystifying 2D-LC PDF here.

cover of agilent supplement 1114

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

Loading the Molecular Dice
Pharma and Biopharma
Loading the Molecular Dice

December 12, 2024

2 min read

How a framework for controlling molecular reactions at the atomic scale has potential implications for nanotechnology, pharmaceutical synthesis, and clean energy research

CD-MS: To Megadalton and Beyond
Pharma and Biopharma
CD-MS: To Megadalton and Beyond

October 1, 2024

10 min read

Charge-detection mass spectrometry (CD-MS) has extended the range of MS to gigadalton-sized viruses and polymers; and with a commercial instrument in development and exciting new applications in complex protein mixtures, maturity beckons

New NMR Technique Enables Direct Detection of Molecular Chirality
Pharma and Biopharma
New NMR Technique Enables Direct Detection of Molecular Chirality

October 1, 2024

1 min read

Researchers develop an NMR method to distinguish between enantiomers without the need for chiral agents

Mass Spec Imaging Meets Proteomics
Pharma and Biopharma
Mass Spec Imaging Meets Proteomics

October 2, 2024

2 min read

Researchers combine tissue imaging with proteomics to shed light on the neurotoxic effects associated with HIV medication Efavirenz treatment

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.